Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial
Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder R, Fellstrom B, Settembre N, Malikov S, Rossignol P, Zannad F (2020)
Publication Type: Journal article
Publication year: 2020
Journal
Book Volume: 13
Pages Range: 116-122
Journal Issue: 1
DOI: 10.1093/ckj/sfz048
Abstract
Background. The impact of arteriovenous fistula (AVF) or graft (AVG) thrombosis on mortality has been sparsely studied. This study investigated the association between AVF/AVG thrombosis and all-cause and cardiovascular mortality.
Authors with CRIS profile
Involved external institutions
Université de Lorraine
France (FR)
University of Oslo
Norway (NO)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
University of Glasgow
United Kingdom (GB)
Centre Hospitalier Universitaire de Nancy / CHU Hôpitaux de Brabois
France (FR)
France (FR)
University of Oslo
Norway (NO)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
University of Glasgow
United Kingdom (GB)
Centre Hospitalier Universitaire de Nancy / CHU Hôpitaux de Brabois
France (FR)
How to cite
APA:
Girerd, S., Girerd, N., Frimat, L., Holdaas, H., Jardine, A.G., Schmieder, R.,... Zannad, F. (2020). Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial. Clinical Kidney Journal, 13(1), 116-122. https://doi.org/10.1093/ckj/sfz048
MLA:
Girerd, Sophie, et al. "Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortar in haemodialysis patients from the AURORA trial." Clinical Kidney Journal 13.1 (2020): 116-122.
BibTeX: Download